The Scripps Research Institute
  News Room Contacts  
  Information for Journalists  
  News  
  Resources  
  Publications  
  Calendar of Events  

 

 

News and Publications


Integrin Structure and Function

Y. Takada, T. Kamata, T. Tarui, K. Yokoyama, W. Puzon-McLaughlin, X. Zhang

Integrins are a family of /ß heterodimers of cell adhesion receptors that mediate interactions between cells and between cells and the extracellular matrix. Interactions between integrins and their ligands are critical in the pathogenesis of many diseases and thus are therapeutic targets.

STRUCTURE AND FUNCTION OF THE ß I DOMAIN

The N-terminal region of the ß subunit is currently the subject of much interest because this region is critical for ligand binding and the regulation of binding. The I or A domain, a set of inserted sequences consisting of about 200 amino acid residues, which is present in several integrin subunits, is important in ligand binding and receptor activation. The N-terminal region of the ß subunit may have a similar structure. We recently detected 8 conserved oxygenated residues critical for ligand binding in several separate predicted loop structures in the ß I domain (Fig. 1). These conserved residues probably constitute multiple binding sites for ligands and cations within the ß I domain and thus are ubiquitously involved in ligand binding regardless of the ligand or the integrin.

We observed that a large predicted loop region (residues 176--199 of ß1) is diverse among the ß subunits. We hypothesized that this predicted loop (especially the short disulfide-linked sequence CTSEQNC 187--193 of ß1) is involved in determining the ligand specificity of integrins. We designed experiments with vß1 and vß3 integrins to ascertain whether this diverse sequence is involved in determining the ligand specificity of integrins. The integrin vß3 recognizes a wide variety of ligands, including fibronectin, fibrinogen, von Willebrand factor, and vitronectin; vß1 is specific to fibronectin.

We found that when the sequence CTSEQNC 187--193 of ß1 is replaced with the corresponding CYDMKTTC sequence of ß3, the ligand specificity of vß1 is altered. The mutant integrin (vß1-3-1), like vß3, recognizes fibrinogen, von Willebrand factor, and vitronectin (a gain-of-function effect). The mutant is recruited to focal contacts on fibrinogen and vitronectin, a finding that suggests that it transduces intracellular signals on adhesion. The reciprocal ß3-1-3 mutation blocks binding of vß3 to these multiple ligands and to a function-blocking antibody to vß3. These results suggest that this highly divergent sequence is a key determinant of integrin-ligand specificity. The data also support a recently proposed model of the ß I domain in which this short disulfide-linked sequence (CTSEQNC 187--193 in ß1, and CYDMKTTC in ß3) is located in the ligand-binding site.

A NEW LIGAND FOR INTEGRIN /alphasb/Vß3

Metalloprotease/disintegrin/cysteine-rich proteins (MDCs) are membrane-anchored proteins that have a metalloprotease domain and a disintegrin-like domain. MDCs are potential ligands for integrins, because most snake venom disintegrins interact with integrins IIbß3 and vß3. MDC-15 (metargidin) has an arginine--glycine--aspartic acid (RGD) sequence in its disintegrin-like domain and is widely expressed in various tissues and cells, including endothelial cells and smooth muscle cells.

We used the recombinant disintegrin-like domain of MDC-15 to determine the receptor specificities of MDC-15. We discovered that this recombinant disintegrin-like domain specifically interacts with integrin vß3 but not with other RGD-dependent or RGD-independent integrins tested, including IIbß3. In contrast, most snake venom disintegrins bind to both IIbß3 and vß3. We also found that the integrin specificity of the recombinant disintegrin-like domain is mediated by the RGD tripeptide and the flanking sequence of the tripeptide, as is the case in snake venom disintegrins. These results suggest that MDC-15 may be involved in vß3-mediated cell-cell adhesion.

PUBLICATIONS

King, S.L., Kamata, T., Cunningham, J.A., Emsley, J., Liddington, R.C., Takada, Y., Bergelson, J.M. Echovirus 1 interaction with the human very late antigen-2 (integrin 2ß1) I domain: Identification of two independent virus contact sites distinct from the metal ion-dependent adhesion site residues. J. Biol. Chem. 272:28518, 1997.

Mould, A.P., Garratt, A.N., Puzon-McLaughlin, W., Takada, Y., Humphries, M.J. Allosteric regulation of integrin function by divalent cations: Evidence that divalent-cation induced conformational changes lead to the exposure of ligand binding sites within integrin 5ß1. Biochem. J. 331:821, 1998.

Takada, Y., Kamata, T., Irie, A., Puzon-McLaughlin, W., Zhang, X.-P. Structural basis of integrin-mediated signal transduction (a review). Matrix Biol. 16:143, 1997.

Tsuchida, J., Ueki, S., Takada, Y., Saito, Y., Takagi, J. The 'ligand-induced conformational change' of 5ß1 integrin. J. Cell Sci. 111:1759, 1998.

Zhang, X.-P., Kamata, T., Yokoyama, K., Puzon-McLaughlin, W., Takada, Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin vß3. J. Biol. Chem. 273:7345, 1998.

 

 







Copyright © 2004 TSRI.